A detailed history of Johnson Investment Counsel Inc transactions in Sanofi stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 14,547 shares of SNY stock, worth $694,037. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,547
Previous 10,259 41.8%
Holding current value
$694,037
Previous $497,000 68.61%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$48.54 - $58.53 $208,139 - $250,976
4,288 Added 41.8%
14,547 $838,000
Q2 2024

Aug 08, 2024

SELL
$45.39 - $50.36 $14,161 - $15,712
-312 Reduced 2.95%
10,259 $497,000
Q1 2024

May 09, 2024

SELL
$45.75 - $52.48 $18,208 - $20,887
-398 Reduced 3.63%
10,571 $513,000
Q4 2023

Feb 07, 2024

BUY
$43.13 - $54.79 $151,558 - $192,532
3,514 Added 47.14%
10,969 $545,000
Q3 2023

Nov 13, 2023

BUY
$50.95 - $55.2 $7,540 - $8,169
148 Added 2.03%
7,455 $399,000
Q2 2023

Aug 10, 2023

BUY
$50.45 - $57.18 $101,808 - $115,389
2,018 Added 38.15%
7,307 $393,000
Q1 2023

May 15, 2023

SELL
$45.86 - $54.45 $147,073 - $174,621
-3,207 Reduced 37.75%
5,289 $287,000
Q4 2022

Feb 14, 2023

SELL
$38.86 - $48.55 $3,031 - $3,786
-78 Reduced 0.91%
8,496 $411,000
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $2,903 - $7,839
78 Added 0.92%
8,574 $326,000
Q2 2022

Aug 15, 2022

BUY
$48.99 - $57.46 $87,153 - $102,221
1,779 Added 26.49%
8,496 $425,000
Q1 2022

May 11, 2022

SELL
$48.48 - $53.65 $332,572 - $368,039
-6,860 Reduced 50.53%
6,717 $345,000
Q4 2021

Feb 15, 2022

BUY
$47.07 - $52.35 $5,036 - $5,601
107 Added 0.79%
13,577 $680,000
Q3 2021

Nov 12, 2021

SELL
$47.89 - $53.12 $431,297 - $478,398
-9,006 Reduced 40.07%
13,470 $649,000
Q2 2021

Aug 13, 2021

SELL
$49.36 - $54.25 $63,082 - $69,331
-1,278 Reduced 5.38%
22,476 $1.18 Million
Q1 2021

May 14, 2021

SELL
$45.46 - $50.51 $84,101 - $93,443
-1,850 Reduced 7.23%
23,754 $1.18 Million
Q4 2020

Feb 12, 2021

SELL
$45.3 - $51.62 $58,663 - $66,847
-1,295 Reduced 4.81%
25,604 $1.24 Million
Q3 2020

Nov 16, 2020

SELL
$49.47 - $53.77 $23,003 - $25,003
-465 Reduced 1.7%
26,899 $1.35 Million
Q2 2020

Aug 13, 2020

SELL
$42.91 - $52.5 $98,907 - $121,012
-2,305 Reduced 7.77%
27,364 $1.4 Million
Q1 2020

May 20, 2020

SELL
$38.02 - $51.66 $114,440 - $155,496
-3,010 Reduced 9.21%
29,669 $1.3 Million
Q4 2019

Feb 13, 2020

SELL
$44.25 - $50.86 $14,691 - $16,885
-332 Reduced 1.01%
32,679 $1.64 Million
Q3 2019

Nov 14, 2019

BUY
$40.34 - $46.64 $1.33 Million - $1.54 Million
33,011 New
33,011 $1.53 Million
Q1 2019

May 13, 2019

SELL
$40.83 - $45.43 $318,555 - $354,444
-7,802 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$41.48 - $45.59 $6,387 - $7,020
-154 Reduced 1.94%
7,802 $338,000
Q3 2018

Nov 14, 2018

SELL
$40.0 - $44.84 $3,480 - $3,901
-87 Reduced 1.08%
7,956 $355,000
Q2 2018

Aug 14, 2018

BUY
$37.63 - $41.22 $940 - $1,030
25 Added 0.31%
8,043 $321,000
Q1 2018

May 15, 2018

BUY
$38.98 - $45.76 $1,598 - $1,876
41 Added 0.51%
8,018 $321,000
Q4 2017

Feb 14, 2018

SELL
$42.86 - $50.61 $6,471 - $7,642
-151 Reduced 1.86%
7,977 $343,000
Q3 2017

Nov 14, 2017

BUY
$47.04 - $50.34 $382,341 - $409,163
8,128
8,128 $404,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.